Cyclin E and prognosis in patients with breast ... [N Engl J Med. 2002] - PubMed

loading

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome. [Breast Cancer Res. 2004]
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.
Akli S, Keyomarsi K. Breast Cancer Res. 2004; 6(5):188-91. Epub 2004 Jul 7.
Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies. [Cancer Invest. 2006]
Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies.
Wang L, Shao ZM. Cancer Invest. 2006 Oct; 24(6):581-7.
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype. [Hum Pathol. 2008]
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D, Nielsen TO, Cheang MC, Foulkes WD. Hum Pathol. 2008 Oct; 39(10):1431-7. Epub 2008 Jul 11.
Review Lower molecular weight forms of cyclin E--super activators of the cell cycle? [Cell Cycle. 2003]
Review Lower molecular weight forms of cyclin E--super activators of the cell cycle?
Stighall M, Berglund P, Landberg G. Cell Cycle. 2003 Sep-Oct; 2(5):458-60.
Review Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel? [Adv Exp Med Biol. 2007]
Review Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel?
Lambert L, Keyomarsi K. Adv Exp Med Biol. 2007; 608:52-69.

Review Evolving therapies and FAK inhibitors for the treatment of cancer. [Anticancer Agents Med Chem. 2010]
Review Evolving therapies and FAK inhibitors for the treatment of cancer.
Dunn KB, Heffler M, Golubovskaya VM. Anticancer Agents Med Chem. 2010 Dec; 10(10):722-34.
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. [Proc Natl Acad Sci U S A. 2010]
DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.
Lemée F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C, et al. Proc Natl Acad Sci U S A. 2010 Jul 27; 107(30):13390-5. Epub 2010 Jul 12.
The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing. [Proc Natl Acad Sci U S A. 2008]
The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing.
Nguyen HH, Aronchik I, Brar GA, Nguyen DH, Bjeldanes LF, Firestone GL. Proc Natl Acad Sci U S A. 2008 Dec 16; 105(50):19750-5. Epub 2008 Dec 8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Cyclin E and prognosis in patients with breast cancer.
Cyclin E and prognosis in patients with breast cancer.
N Engl J Med. 2002 Nov 14 ;347(20):1546-7.

PubMed
Limb salvage and amputation in survivors of pediatric lower-extremity bone tumor...
Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: what are the long-term implications?
J Clin Oncol. 2002 Nov 15 ;20(22):4493-501.

PubMed
Randomized study to evaluate the use of high-dose therapy as part of primary tre...
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
J Clin Oncol. 2002 Nov 15 ;20(22):4413-9.

PubMed
Validation of recall of breast and cervical cancer screening by women in an ethn...
Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population.
Prev Med. 2002 Nov ;35(5):463-73.

PubMed
Application of the protection motivation theory to genetic testing for breast ca...
Application of the protection motivation theory to genetic testing for breast cancer risk.
Prev Med. 2002 Nov ;35(5):453-62.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed